Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joe Taylor
Observed names:
J Taylor,
J. Taylor
Institution:
Institute of Cancer Research
Observed institutions:
Institute of Cancer Research,
Cancer Research UK,
Southampton General Hospital,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Southampton
ORCID:
0000-0002-4502-0860
Observed ORCID:
0000-0002-4502-0860
OpenAlex ID:
A5055617006
Works
9
Awards
1
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
2010
·
S Lee
, N Syed
, et al.
·
British Journal of Cancer
·
38
PDF
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells
2021
·
Sarah Wilmore
, Karly-Rai Rogers-Broadway
, et al.
·
Cellular and Molecular Life Sciences
·
36
PDF
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
2021
·
Beatriz Valle-Argos
, Giorgia Chiodin
, et al.
·
Scientific Reports
·
16
PDF
Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms
2020
·
Joe Taylor
, Alison M Yeomans
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
11
PDF
B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells
2022
·
Joe Taylor
, Sarah Wilmore
, et al.
·
Cellular Signalling
·
8
PDF
Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities
2026
·
Nick R. Waldron
, Diogo Silva
, et al.
·
British Journal of Cancer
·
5
PDF
Abstract B032: Induction of the unfolded protein response unveils a vulnerability of advanced prostate cancer cells to BH3 mimetics
2026
·
Juan M. Jiménez-Vacas
, Jonathan Welti
, et al.
·
Cancer Research
Impact of pembrolizumab on health outcomes and productivity in earlier-stage cancers within the US Medicare population
2025
·
Yizhen Lai
, Sam Greenall
, et al.
·
Journal of Medical Economics
PDF
Transcriptional silencing of dual specificity phosphatase type 2 (DUSP2) abrogates drug-induced apoptosis and predicts cisplatin resistance in head and neck squamous carcinomas
2008
·
M. Gasco
, N. Syed
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
114
H-index:
5
I10-index:
4
Year
Topic
Type